Profil
Anne Johnson is currently Chief Accounting Officer at Atai Beckley, Inc. Formerly, Ms. Johnson was Corporate Controller at Chimerix, Inc., Vice President-Finance at Xanodyne Pharmaceuticals, Inc., Controller at Aruvant Sciences, Inc., and Chief Financial & Accounting Officer at Atai Beckley NV.
Ms. Johnson completed undergraduate education at The University of North Carolina at Wilmington.
Postes actifs de Anne Johnson
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Anne Johnson
| Sociétés | Poste | Fin |
|---|---|---|
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Directeur Financier/CFO | - |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning | Comptroller/Controller/Auditor | - |
| CHIMERIX, INC. | Comptroller/Controller/Auditor | - |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur Financier/CFO | - |
Formation de Anne Johnson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Chimerix, Inc.
Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
The University of North Carolina at Wilmington
The University of North Carolina at Wilmington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning | Health Technology |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
















